Baxter Raises Full-Year 2008 Outlook Following Strong Second-Quarter Financi... (p ...)

HOME >> BIOLOGY >> TECHNOLOGY

Baxter Raises Full-Year 2008 Outlook Following Strong Second-Quarter Financial Results

Date:7/17/2008

p> @ @

Q2 Q2 Actual Constant

2008 2007 Rates Rates

--------------------------------------------------------------------------

BioScience (1)

United States $590 $532 11% 11%

International 795 658 21% 6%

Total $1,385 $1,190 16% 8%

--------------------------------------------------------------------------

Medication Delivery

United States $525 $535 (2%) (2%)

International 639 504 27% 13%

Total $1,164 $1,039 12% 5%

--------------------------------------------------------------------------

Renal

United States $97 $95 2% 2%

International 501 458 9% (2%)

Total $598 $553 8% (1%)

--------------------------------------------------------------------------

Baxter excluding Transfusion Therapies

United States $1,212 $1,162 4% 4%

International 1,935 1,620 19% 6%

Total $3,147 $2,782 13% 5%

---------------------------
'/>"/>

SOURCE Baxter International Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Related biology technology :

1. Bioniche Pharma Acquires Baxters ENLON(R) and ENLON-PLUS(R)
2. Baxters Board of Directors Declares Quarterly Dividend
3. Baxter Reports Solid First Quarter Financial Results and Raises Full-Year Outlook
4. Baxters V-Link Luer-Activated Device With VitalShield Protective Coating Now Available For Hospitals
5. Baxter Announces FDA Approval of ARTISS Slow-Setting Fibrin Sealant in Treatment of Burn Patients
6. Baxters Board of Directors Approves New Share Repurchase Authorization of $2 Billion
7. Baxter and Its Foundation Contribute Nearly $53 Million in 2007 to Address Critical Needs Locally and Globally
8. Baxter to Proceed With Recall of Remaining Heparin Sodium Vial Products
9. Baxter Declares Quarterly Dividend
10. Baxter Provides Update on Heparin Reactions
11. Baxters Costa Rica Facility Recognized With Shingo Prize for Excellence in Manufacturing

Post Your Comments:

(Date:5/21/2013)... Milwaukee, Wisc. (PRWEB) May 21, 2013 ... equipment parts distributor , will be exhibiting for ... the Advancement of Medical Instrumentation (AAMI) 2013 Conference ... manage, purchase, support, distribute, and manufacture healthcare technologies. ... 1-3 in Long Beach, California. , The ...

(Date:5/21/2013)... 2013 Clinverse, Inc. , ... clinical trials, announced today it has formed a ... Clinverse’s ClinPay® FLS eClinical commerce platform aggregates data ... SpendMD ™, Aggregate Spend Solutions’ recently-launched flagship ... and reporting transfer of value at investigator meetings ...

(Date:5/21/2013)... 2013 As the R&D sector ... within the industry to deliver better products, faster. ... pharma companies often means turning big ideas into ... in collaboration with Sensidose AB and Recipharm, is ... products to market sooner. The partnership resulted in ...

(Date:5/21/2013)... Md. , May 21, 2013 MacroGenics, ... 1 study of margetuximab (MGAH22), an Fc-modified chimeric ... tumors expressing the HER2 oncoprotein," will be presented ... Society of Clinical Oncology during the Developmental Therapeutics ... 3 at 4:15 – 4:30 PM. The presentation ...

Breaking Biology Technology:Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2 Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2 Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3 The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2 MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2 MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3

[0] Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo [0] Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC [0] The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks [0] MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer

... 7, 2011 Reportlinker.com ... report is available in its catalogue: ... Shares, Strategies, and Forecasts, Worldwide, 2011 ... http://www.reportlinker.com/p0569001/Tele-Health-Monitoring-Market-Shares-Strategies-and-Forecasts-Worldwide-2011-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=e-Healthcare WinterGreen Research ...

... is available in German . ... supplements. However, the production of this "functional food" has ... enough to survive conventional production processes. Researchers from Technische ... that allows the use of thus far unutilized probiotics. ...

... are among the oldest known life-forms, but they are ... that these single-celled microorganisms were designated as a domain ... eukaryotes. Robert Gunsalus, a UCLA professor ... in Archaea because of their ability to ...

Tele-Health Monitoring: Market Shares, Strategies, and Forecasts, Worldwide, 2011 to 2017 TUM researchers develop environmentally friendly process to improve storage stability of probiotics Old life capable of revealing new tricks after all

(Date:5/21/2013)... Researchers at the University of Illinois at Chicago College of ... and stores fat -- its main energy source -- and ... disease, under a new $2 million, 4-year grant from the ... heart changes how it uses fuel for energy. These changes ... disease and are different in men and women, says E. ...

(Date:5/21/2013)... charted the path of insulin action in cells in ... blueprint for understanding what goes wrong in diabetes. ... Professor David James from Sydney,s Garvan Institute of Medical ... of the prestigious journal Cell Metabolism . , ... very important role in the body because it helps ...

(Date:5/20/2013)... is known about the effect of physical education (PE) ... University finds that increasing the amount of time that ... of obesity. , The study represents some of the ... youth obesity, and is forthcoming in the Journal ... of the study can be viewed at: http://www.sciencedirect.com/science/article/pii/S0167629613000556 ...

Breaking Biology News(10 mins):Do men's and women's hearts burn fuel differently? 2 Insight into the dazzling impact of insulin in cells 2 Insight into the dazzling impact of insulin in cells 3 Gym class reduces probability of obesity, study finds for first time 2

[0] Do men's and women's hearts burn fuel differently?[0] Insight into the dazzling impact of insulin in cells [0] Gym class reduces probability of obesity, study finds for first time

... A study published in this week,s online issue of ... sensitive method for detecting methylation-associated cancers. ... of methyl groups has been established as a common ... levels of DNA methylation, which effectively disrupt the genes ...

... research shows that air pollution in eastern China has reduced ... and decreased by 23 percent the number of days of ... results suggest that bad air quality might be affecting the ... health and environmental problems. The study links for the ...

... Dresden research team used laser tweezers to measure the ... track. The team found that also within our ... are restrained in its operationusually by far not as ... experimental measurements of protein friction could help researchers to ...

Cached Biology News:Researchers develop new, more-sensitive assay for detecting DNA methylation in colon cancer 2 Researchers develop new, more-sensitive assay for detecting DNA methylation in colon cancer 3 The sky is not falling: Pollution in eastern China cuts light, useful rainfall 2 The sky is not falling: Pollution in eastern China cuts light, useful rainfall 3 The sky is not falling: Pollution in eastern China cuts light, useful rainfall 4 Bionanomachines -- proteins as resistance fighters 2

Researchers develop new, more-sensitive assay for detecting DNA methylation in colon cancer The sky is not falling: Pollution in eastern China cuts light, useful rainfall Bionanomachines -- proteins as resistance fighters

Request Info...

Applications: (+) Immunocytochemistry and immunohistochemistry...

RABBIT ANTI WARFARIN...

Request Info...

Biology Products:

Rat IFN-gamma ELISpot Development Kit from R&D Systems Normal Goat Serum from Cayman Chemical Rabbit Anti-WARFARIN Polyclonal Antibody, Unconjugated from AbD Serotec MagCellect Rat CD4+ T Cell Isolation Kit from R&D Systems